In 1919 was created Petercam, which is appeared as VC. The main office of represented VC is situated in the Brussels. The venture was found in Europe in Belgium.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight MDxHealth. We can highlight the next thriving fund investment areas, such as Biotechnology, Health Diagnostics. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Petercam, startups are often financed by Idinvest Partners. The meaningful sponsors for the fund in investment in the same round are Valiance Asset Management, Biovest International. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs.
The top activity for fund was in 2013. The top amount of exits for fund were in 2006. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars.
|23M||25 Jun 2013||United States, Irvine|
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.